We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

143 hedge funds and large institutions have $669M invested in Albany Molecular Research Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 46 increasing their positions, 42 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

85% more call options, than puts

Call options by funds: $1.95M | Put options by funds: $1.05M

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

22% more capital invested

Capital invested by funds: $548M → $669M (+$122M)

8% more funds holding

Funds holding: 132 → 143 (+11)

10% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 42

Holders
143
Holders Change
+11
Holders Change %
+8.33%
% of All Funds
4.15%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
25
Increased
46
Reduced
42
Closed
14
Calls
$1.95M
Puts
$1.05M
Net Calls
+$899K
Net Calls Change
-$5.29M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$19.3M
2
BM
Bridger Management
New York
+$16.7M
3
WIC
Wood Investment Counsel
Colorado
+$15M
4
PIP
Permian Investment Partners
Texas
+$14.1M
5
HM
HealthCor Management
New York
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$19.9M
2
Renaissance Technologies
Renaissance Technologies
New York
-$7.59M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.79M
4
DCM
Decade Capital Management
New York
-$5.3M
5
DS
DRW Securities
Illinois
-$4.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
51
Two Sigma Investments
New York
$1.33M -$1.59M -77,693 -56%
Asset Management One
52
Asset Management One
Japan
$1.3M – – –
Wells Fargo
53
Wells Fargo
California
$1.29M +$1.16M +56,518 +3,026%
AQR Capital Management
54
AQR Capital Management
Connecticut
$1.27M – – –
HK
55
Horizon Kinetics
New York
$1.24M – – –
MERSOM
56
Municipal Employees' Retirement System of Michigan
Michigan
$1.21M +$6.14K +300 +0.5%
Public Employees Retirement Association of Colorado
57
Public Employees Retirement Association of Colorado
Colorado
$1.19M +$1.11M +54,040 New
EI
58
EAM Investors
California
$1.19M – – –
Prudential Financial
59
Prudential Financial
New Jersey
$1.16M +$135K +6,600 +14%
BF
60
BOK Financial
Oklahoma
$1.15M +$1.07M +52,260 New
NFA
61
Nationwide Fund Advisors
Ohio
$1.08M +$87.3K +4,263 +10%
GCP
62
GSA Capital Partners
United Kingdom
$1.06M +$987K +48,189 New
Public Sector Pension Investment Board (PSP Investments)
63
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$978K +$49.1K +2,400 +6%
FSA
64
Franklin Street Advisors
North Carolina
$970K +$487K +23,800 +118%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$960K +$9.15K +447 +1%
Two Sigma Advisers
66
Two Sigma Advisers
New York
$936K -$143K -7,000 -14%
Charles Schwab
67
Charles Schwab
California
$927K -$355K -17,320 -29%
FQ
68
First Quadrant
California
$876K – – –
WIC
69
Woodmont Investment Counsel
Tennessee
$857K -$192K -9,400 -19%
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$845K +$15.2K +740 +2%
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
$812K +$77.8K +3,800 +12%
SIM
72
Spark Investment Management
New York
$763K +$352K +17,200 +99%
SO
73
STRS Ohio
Ohio
$742K -$94.2K -4,600 -12%
TA
74
Teachers Advisors
New York
$734K – – –
Royal Bank of Canada
75
Royal Bank of Canada
Ontario, Canada
$726K -$5.32K -260 -0.8%
1 2
3
4 5

AMRI Hedge Fund Activity: Q3 2014 in Review

143 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2014, worth a combined $669M — up 22% from $548M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new AMRI positions and 14 closed out — a net gain of 11 holders — while 46 added to existing stakes and 42 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $19.3M. The largest seller was Visium Asset Management, cutting an estimated $19.9M.

  • 143 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2014, up from 132 in Q2 2014.
  • Funds reported $669M of Albany Molecular Research Inc stock for Q3 2014, up 22% quarter-over-quarter.
  • 25 funds opened new Albany Molecular Research Inc positions in Q3 2014 and 14 closed out, a net change of +11 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2014 was Morgan Stanley, an estimated $19.3M added.
  • The largest Albany Molecular Research Inc seller in Q3 2014 was Visium Asset Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q3 2014.